Rules Navigator

Register

New York attorney general charges former Emergent BioSolutions chief with insider trading

Photo of New York State Attorney General Letitia James standing in front of the seal of the Office of the Attorney General with a blue background.
Photo: Michael M. Santiago/Getty Images

Kevin Kinsella

 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Robert G Kramer is accused of selling his company shares before publicly revealing contamination issues with his company’s COVID-19 vaccine production.

The Office of the New York Attorney General (OAG) has announced it is suing former Emergent BioSolutions CEO Robert Kramer for insider trading.

The OAG also announced a settlement with Emergent for approving Kramer’s illegal trading plan.

In the summer of 2020, Emergent, which contracts with pharmaceutical

Following

Register for free to keep reading

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free
Sign in
, , , , , ,